Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens

DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304, USA.
Journal of Experimental Medicine (Impact Factor: 12.52). 10/2001; 194(6). DOI: 10.1084/jem.194.6.863
Source: PubMed Central


Toll-like receptors (TLRs) are ancient microbial pattern recognition receptors highly conserved from Drosophila to humans. To investigate if subsets of human dendritic cell precursors (pre-DC), including monocytes (pre-DC1), plasmacytoid DC precursors (pre-DC2), and CD11c+ immature DCs (imDCs) are developed to recognize different microbes or microbial antigens, we studied their TLR expression and responses to microbial antigens. We demonstrate that whereas monocytes preferentially express TLR 1, 2, 4, 5, and 8, plasmacytoid pre-DC strongly express TLR 7 and 9. In accordance with these TLR expression profiles, monocytes respond to the known microbial ligands for TLR2 (peptidoglycan [PGN], lipoteichoic acid) and TLR4 (lipopolysaccharide), by producing tumor necrosis factor (TNF)-α and interleukin (IL)-6. In contrast, plasmacytoid pre-DCs only respond to the microbial TLR9-ligand, CpG-ODNs (oligodeoxynucleotides [ODNs] containing unmethylated CpG motifs), by producing IFN-α. CD11c+ imDCs preferentially express TLR 1, 2, and 3 and respond to TLR 2-ligand PGN by producing large amounts of TNF-α, and to viral double-stranded RNA-like molecule poly I:C, by producing IFN-α and IL-12. The expression of distinct sets of TLRs and the corresponding difference in reactivity to microbial molecules among subsets of pre-DCs and imDCs support the concept that they have developed through distinct evolutionary pathways to recognize different microbial antigens.

Download full-text


Available from: J. Fernando Bazan,
  • Source
    • "Although various TLRs, such as TLR3, TLR4, TLR5, TLR7 and TLR8 induce immune activation, others, e.g., TLR2 can silence immune responses through tolerance induction of DCs. The TLR2 activation induces IL-10 production, inhibits TLR7/TLR9 signaling and prevents interferon (IFN-α and -β) production (Kadowaki et al., 2001). Induction of immunological tolerance, specific for transplant or self-antigens while maintaining reactivity to other antigens, is an important goal in transplantation medicine and autoimmunity (Hilkens et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: immunosuppressive agents in the treatment of many autoimmune and allergic diseases. Aim: This study investigated the effect of the steroid dexamethasone (DEX) on maturation and differentiation of DCs derived from monocytes. In addition, an in vivo experiment was conducted to investigate whether treatment of mice with DEX has immunomodulatory effect on murine splenic DCs. Methods: In vitro experiment: Immature DCs were generated by incubating peripheral blood monocytes with cytokine cocktail (GM-CSF+IL-4) for 9 days. Phenotypic analysis of the DCs’ specific cell marker CD83 was performed by flow cytometry. In vivo experiment: Mice were randomly divided into 5 groups according to the dose of i.p., injection of DEX and duration of treatment. The murine splenic DCs were isolated and phenotyped for CD83 and CD11c by flow cytometry. Results: Addition of 1 μM DEX to the culture on day 7 or 8 resulted in a significant increase in the CD83 expression. The in vivo experiment showed that i.p. injection of DEX significantly increased the expression of CD83 on splenic DCs. Mice groups treated with a single dose of 20 mg kgG1 DEX showed a significant decrease of percentage of CD11c+CD83+ splenic DCs. Conclusion: DEX induced the DCs to be more tolerogenic both in vitro and in vivo. It could be suggested that DEX can trigger immunosuppressive effect via modulating the expression of the cell surface markers of DCs. Key words: Dendritic cells, dexamethasone, CD83, CD11c, murine splenic cells
  • Source
    • "To ensure that 24F4A specifically inhibited pDC-derived IFN-I, PBMC from healthy donors were stimulated with the TLR3 ligand poly(I:C). PDCs do not express TLR3 and therefore do not contribute to IFN-I production induced by poly(I:C) in PBMC culture (Kadowaki et al, 2001; Matsumoto et al, 2003). As expected, 24F4A inhibited TLR9-induced IFNa but did not impact TLR3-induced IFNa production by PBMC (Supplementary Fig S2). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Type I interferons (IFN-I) are implicated in the pathogenesis of systemic lupus erythematosus (SLE). In SLE, immune complexes bind to the CD32a (FcγRIIa) receptor on the surface of plasmacytoid dendritic cells (pDCs) and stimulate the secretion of IFN-I from pDCs. BDCA2 is a pDC-specific receptor that, when engaged, inhibits the production of IFN-I in human pDCs. BDCA2 engagement, therefore, represents an attractive therapeutic target for inhibiting pDC-derived IFN-I and may be an effective therapy for the treatment of SLE. In this study, we show that 24F4A, a humanized monoclonal antibody (mAb) against BDCA2, engages BDCA2 and leads to its internalization and the consequent inhibition of TLR-induced IFN-I by pDCs in vitro using blood from both healthy and SLE donors. These effects were confirmed in vivo using a single injection of 24F4A in cynomolgus monkeys. 24F4A also inhibited pDC activation by SLE-associated immune complexes (IC). In addition to the inhibitory effect of 24F4A through engagement of BDCA2, the Fc region of 24F4A was critical for potent inhibition of IC-induced IFN-I production through internalization of CD32a. This study highlights the novel therapeutic potential of an effector-competent anti-BDCA2 mAb that demonstrates a dual mechanism to dampen pDC responses for enhanced clinical efficacy in SLE. © 2015 Biogen Idec. Published under the terms of the CC BY 4.0 license.
    EMBO Molecular Medicine 03/2015; 7(4). DOI:10.15252/emmm.201404719 · 8.67 Impact Factor
  • Source
    • "Like their primary blood–derived counterparts, only the culturederived pDCs produced IFN- in response to CpG (Fig. 3 b; Ito et al., 2005; Liu, 2005). Similarly, culture-derived and primary CD141 + cDCs produced the highest amount of IFN- and IL-12 in response to Poly(I:C) (Fig. 3 b; Kadowaki et al., 2001; Poulin et al., 2010). We conclude that MS5+FSG supports differentiation of multiple hematopoietic lineages from their progenitors, including human pDCs and CD1c + and CD141 + cDCs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Two subsets of conventional dendritic cells (cDCs) with distinct cell surface markers and functions exist in mouse and human. The two subsets of cDCs are specialized antigen-presenting cells that initiate T cell immunity and tolerance. In the mouse, a migratory cDC precursor (pre-CDC) originates from defined progenitors in the bone marrow (BM). Small numbers of short-lived pre-CDCs travel through the blood and replace cDCs in the peripheral organs, maintaining homeostasis of the highly dynamic cDC pool. However, the identity and distribution of the immediate precursor to human cDCs has not been defined. Using a tissue culture system that supports the development of human DCs, we identify a migratory precursor (hpre-CDC) that exists in human cord blood, BM, blood, and peripheral lymphoid organs. hpre-CDCs differ from premonocytes that are restricted to the BM. In contrast to earlier progenitors with greater developmental potential, the hpre-CDC is restricted to producing CD1c(+) and CD141(+) Clec9a(+) cDCs. Studies in human volunteers demonstrate that hpre-CDCs are a dynamic population that increases in response to levels of circulating Flt3L. © 2015 Breton et al.
    Journal of Experimental Medicine 02/2015; 212(3). DOI:10.1084/jem.20141441 · 12.52 Impact Factor
Show more